Filing Details
- Accession Number:
- 0001415889-24-006843
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 18:20:28
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 18:20:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1127537 | Pulmonx Corp | LUNG | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650427 | John Mckune | C/O Pulmonx Corporation 700 Chesapeake Drive Redwood City CA 94063 | Interim Cfo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-01 | 155 | $9.06 | 48,333 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-01 | 254 | $9.06 | 48,079 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-01 | 669 | $9.06 | 47,410 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-03-01 | 14,400 | $0.00 | 61,810 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2024-03-01 | 28,800 | $0.00 | 28,800 | $9.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
28,800 | 2034-02-28 | No | 4 | A | Direct |
Footnotes
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
- Includes 841 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2024.
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
- Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
- The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.